Código QR (código de barras bidimensional)

In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach

The RAS–RAF–MEK–ERK pathway plays a key role in malevolent cell progression in many tumors. The high structural complexity in the upstream kinases limits the treatment progress. Thus, MEK inhibition is a promising strategy since it is easy to inhibit and is a gatekeeper for the many malignant effect...

תיאור מלא

שמור ב:
Principais autores: Muthu Kumar Thirunavukkarasu, Utid Suriya, Thanyada Rungrotmongkol, Ramanathan Karuppasamy
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2021-12-01
סדרה:Pharmaceutics
נושאים:
drug-repositioning
MEK inhibitor
MM/GBSA
Glide docking
MD simulation
MM/PBSA
גישה מקוונת:https://www.mdpi.com/1999-4923/14/1/59
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים